Eualuation of Nonlinear Optimization for Scheduling of follow-up cystoscopies to Detect Recurrent Bladder Cancer

Standard recommendations for patients who have had superficial bladder cancer are in spection by cystoscopy quarterly for a year or two after tumor removal, then half-yearly and yearly. The authors assessed the potential for improvement in scheduling cystoscopies according to probabilistic optimization techniques. Eight hypothetical practices were created, based on retrospective analysis of 918 bladder-cancer-patient charts. Standard and alter native recommendations for the interval to next cystoscopy were compared. The alternatives were derived from patient-specific predictions of future tumor risks (based on the patient's prior recurrence rate and tumor stage and grade) and a nonlinear optimization approach to allocation of the same number of cystoscopies as were available for standard follow-up. The optimization proposed longer intervals between visits for low-risk patients and shorter inter vals for high-risk patients. Overall, optimization reduced expected tumor detection delays by 30%, from 12.6 to 8.7 weeks. When optimization intervals were shorter than standard, cancer was found more often at subsequent cystoscopies (34% vs 27%, p < 0.05), suggesting that the optimization was a better predictor of cancer recurrence. If reduction in tumor-detection delay is the goal of follow-up for recurrent cancers, then urologists can improve monitoring by using probabilistic optimization methods for scheduling cystoscopies. Further understand ing of the accuracy of predictive models for bladder-cancer recurrence rates is desirable. Subsequently, the optimization method developed here may be tested prospectively. Key words: bladder cancer; nonlinear optimization; operations research; follow-up studies; mon itoring; cystoscopy; health services; decision analysis. (Med Decis Making 1991;11:240- 248)

[1]  F. Freiha,et al.  Superficial bladder cancer: the primacy of grade in the development of invasive disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  F. Torti,et al.  The biology and treatment of superficial bladder cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Loening,et al.  Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa. , 1983, The Journal of urology.

[4]  W. Frable,et al.  The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. , 1981, The Journal of urology.

[5]  S. Loening,et al.  Factors influencing the recurrence rate of bladder cancer. , 1980, The Journal of urology.

[6]  B. Lum Intravesical chemotherapy of superficial bladder cancer. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[7]  D J Spiegelhalter,et al.  Evaluation of clinical decision-aids, with an application to a system for dyspepsia. , 1983, Statistics in medicine.

[8]  Ross D. Shachter,et al.  Efficient Scheduling of Cystoscopies in Monitoring for Recurrent Bladder Cancer , 1989, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  H. Huland,et al.  Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients. , 1983, European urology.

[10]  R. Schade,et al.  The association of urothelial abnormalities with neoplasia: a 10-year followup. , 1983, The Journal of urology.

[11]  O. Dalesio,et al.  Does intravesical chemotherapy prevent invasive bladder cancer? , 1984, The Journal of urology.

[12]  S. Loening,et al.  Analysis of bladder tumor recurrence in 178 patients. , 1980, Urology.

[13]  P. Karrer,et al.  Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland. , 1984, The Journal of urology.

[14]  P. Esposti,et al.  The cytologic diagnosis of transitional cell tumors of the urinary bladder and its histologic basis. A study of 567 cases of urinary-tract disorder including 170 untreated and 182 irradiated bladder tumors. , 1970, Acta cytologica.

[15]  G. Farrow,et al.  Benign papilloma or papillary carcinoma of the bladder? , 1973, The Journal of urology.

[16]  P. Mogensen,et al.  Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin and urokinase. , 1983, The Journal of urology.

[17]  W Lutzeyer,et al.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. , 1982, The Journal of urology.

[18]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.